MATUCCI CERINIC, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.353
EU - Europa 20.025
AS - Asia 3.999
SA - Sud America 49
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 25
Totale 56.520
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.236
PL - Polonia 6.508
IT - Italia 3.367
IE - Irlanda 3.189
SE - Svezia 2.606
RU - Federazione Russa 1.460
HK - Hong Kong 1.401
CN - Cina 891
FI - Finlandia 761
SG - Singapore 617
UA - Ucraina 580
DE - Germania 564
TR - Turchia 431
GB - Regno Unito 392
JO - Giordania 243
CH - Svizzera 207
VN - Vietnam 147
IN - India 133
CA - Canada 109
FR - Francia 100
ES - Italia 90
KR - Corea 78
RO - Romania 53
NL - Olanda 44
AT - Austria 25
EU - Europa 23
BE - Belgio 20
BR - Brasile 16
SC - Seychelles 16
AU - Australia 14
JP - Giappone 14
NZ - Nuova Zelanda 11
PE - Perù 10
PT - Portogallo 10
TW - Taiwan 10
CO - Colombia 9
EG - Egitto 9
CZ - Repubblica Ceca 8
IR - Iran 7
HU - Ungheria 6
LV - Lettonia 6
TH - Thailandia 6
CM - Camerun 5
ID - Indonesia 5
MU - Mauritius 5
MX - Messico 5
CL - Cile 4
LT - Lituania 4
AR - Argentina 3
DK - Danimarca 3
EC - Ecuador 3
GT - Guatemala 3
MD - Moldavia 3
NO - Norvegia 3
VE - Venezuela 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
KZ - Kazakistan 2
MA - Marocco 2
PH - Filippine 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
IQ - Iraq 1
KW - Kuwait 1
MK - Macedonia 1
MY - Malesia 1
PK - Pakistan 1
SA - Arabia Saudita 1
SD - Sudan 1
TN - Tunisia 1
TZ - Tanzania 1
UZ - Uzbekistan 1
Totale 56.520
Salva come PNG Salva come JPEG
Città #
Warsaw 6.485
Fairfield 5.481
Chandler 3.203
Dublin 3.171
Woodbridge 2.476
Ashburn 2.438
Seattle 2.175
Cambridge 2.152
Houston 1.899
Wilmington 1.818
Jacksonville 1.020
Princeton 948
Lawrence 738
Ann Arbor 725
Altamura 717
Hong Kong 649
Florence 576
Medford 539
Boardman 510
Boston 484
Izmir 389
Singapore 380
Beijing 376
San Diego 307
Buffalo 285
Shanghai 232
Norwalk 181
Milan 172
Moscow 147
Rome 137
Bern 131
Falls Church 131
Dong Ket 119
New York 115
Hillsboro 112
Kent 105
Andover 83
Pune 81
Los Angeles 75
Toronto 73
Seoul 62
West Jordan 60
Barcelona 56
London 52
Naples 44
Phoenix 38
Timisoara 37
Redwood City 35
Dearborn 33
Turin 30
Unterkulm 27
Bologna 26
Bari 25
Laurel 25
Redmond 25
Vienna 25
Verona 24
Frankfurt Am Main 23
Shenzhen 21
Auburn Hills 19
Düsseldorf 19
Reinach 19
Padova 18
Cagliari 17
Palermo 17
Salerno 17
Brussels 16
Castelliri 16
Hefei 15
Nanjing 15
Tappahannock 15
Guangzhou 13
Old Bridge 13
Catania 12
Chicago 12
Saint Petersburg 12
Bremen 11
Kilburn 11
San Mateo 11
Sesto Fiorentino 11
Washington 11
Birmingham 10
Mountain View 10
Munich 10
Helsinki 9
Hounslow 9
Lappeenranta 9
Lima 9
Napoli 9
Reggio Emilia 9
Taipei 9
Amsterdam 8
Brescia 8
Genoa 8
Jinan 8
Montréal 8
Prato 8
Venice 8
Brno 7
Brugherio 7
Totale 42.986
Salva come PNG Salva come JPEG
Nome #
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 590
Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis 308
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide 239
Il massaggio connettivale e la manipolazione articolare di Mc Mennel sono efficaci per il recupero della funzionalita' della mano nei pazienti con Sclerosi Sistemica (Ssc) 235
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 231
Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone mass determinants using dual energy X-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography. 230
Rheumatologic rehabilitation: towards recommendations 224
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 222
Interstitial lung disease in systemic sclerosis: Where do we stand? 222
In systemic sclerosis, anxiety and depression assessed by hospital anxiety depression scale are independently associated with disability and psychological factors. 221
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis 220
Cyclophosphamide in systemic sclerosis: still in search of a 'real life' scenario. 217
International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis. 217
[Peripheral nervous system in limited systemic sclerosis]. 214
[The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases]. 212
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 210
The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem? 210
The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population. 206
Registry evaluation of digital ulcers in systemic sclerosis 204
Clinical trials in systemic sclerosis: lessons learned and outcomes. 203
Circulating autoantibodies to endothelial progenitor cells: binding characteristics and association with risk factors for atherosclerosis. 203
Serial QuantiFERON TB-Gold in-tube testing during LTBI therapy in candidates for TNFi treatment 203
Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA) 202
Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed. 201
Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. 201
[Vasculogenesis and angiogenesis: vascular damage in systemic sclerosis]. 199
Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study. 197
Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide 195
High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis. 195
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 194
Anti-Fas IgM monoclonal antibody (anti-Fas mAb) effect on haemophilic arthropathy (HA) synoviocytes 194
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 193
Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis. 193
Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). 191
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. 188
Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck 185
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. 184
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population 183
Muscle shortening manoeuvre reduces pain and functional impairment in shoulder impingement syndrome: clinical and ultrasonographic evidence. 179
Treatment For Metatharsalgia By Plantar Insoles And Silicone Orthosis For Toes In Patients With Rheumatoid Arthritis And Osteoarthritis: A Cross-Over Study. 174
Treatment patterns of anti-TNF agents in Italy: an observational study. 172
[Recommendations for starting anti TNF-alpha in patients with ankylosing spondylitis]. 170
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 169
Rehabilitation Of Temporomandibular Joint (TMJ) In Patients With Systemic Sclerosis (SSc). A Comparison Between Two Protocols: Preliminary Results 169
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 163
Rheumatologic rehabilitation: the great expectation for rheumatic patients. 162
Connective Massage and Mc Mennel Joint Manipulation in the Functional Rehabilitation of Systemic Sclerosis (SSc) hand. 161
[Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society]. 158
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. 157
PERINATAL EPIGENETICS: LOW BIRTH WEIGHT AND ADULT ONSET SYSTEMIC SCLEROSIS 156
Efficacia del metodo Resseguier nel trattamento della sindrome fibromialgica 152
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A 148
Cross-sectional and longitudinal evaluation of bone mass and quality in children and young adults with juvenile onset systemic lupus erythematosus (JSLE): role of bone mass determinants analyzed by DXA, PQCT and QUS. 130
Pathophysiology of Hemophilic Arthropathy 130
Fibroblast growth factor 23 (FGF23) gene polymorphism in children with Kawasaki syndrome (KS) and susceptibility to cardiac abnormalities. 127
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 127
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 124
Efficacia dell’utilizzo di un tutore personalizzato (splint) nel trattamento della rizoartrosi del pollice 122
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 120
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 120
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis 119
Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice 119
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 118
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 117
TNF-α/TNF-R System May Represent a Crucial Mediator of Proliferative Synovitis in Hemophilia A 113
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 110
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 110
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 109
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 108
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 106
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis 106
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 106
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 106
AB0976 Association of Vitamin D Receptor Polymorphisms with Juvenile Idiopathic Arthritis (JIA) 105
Ischemia critica degli arti inferiori. Prospettive organizzative e terapeutiche: cellule staminali.Risultati preliminari del trial SCELTA: "Stem Cell Emergency Life Threathening Arteriopathy” 104
A group of patients with Marfan's syndrome, who have finger and toe contractures, displays tendons' alterations upon an ultrasound examination: are these features common among classical Marfan patients? 104
Vitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: a cross-sectional study. 103
Digital ulcers predict a worse disease course in patients with systemic sclerosis 103
Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA). 102
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 102
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 102
Determinants of Vitamin D Levels in Children, Adolescents, and Young Adults with Juvenile Idiopathic Arthritis. 102
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 101
Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis 100
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 99
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 99
Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings. 99
Activin, a grape seed derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. 98
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. 98
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis 98
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 98
Sintomatologia gastrointestinale e qualità di vita dei pazienti affetti da Sclerosi Sistemica 97
Estrogens and neuropeptides in Raynaud's phenomenon. 97
Lidocaine controls pain and allows safe wound bed preparation and debridement of digital ulcers in systemic sclerosis: a retrospective study. 97
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 97
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 97
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis 96
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 96
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 95
Calcinosis in systemic sclerosis: subsets, distribution and complications 95
Totale 15.757
Salva come PNG Salva come JPEG
Categoria #
all - tutte 178.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.606
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.519 0 863 312 917 1.283 1.374 1.285 1.459 1.212 689 901 224
2020/20217.598 741 585 512 918 326 849 314 583 721 1.054 491 504
2021/20225.424 125 543 314 258 253 286 168 375 334 205 781 1.782
2022/202313.376 1.533 2.170 504 1.006 1.113 2.620 1.670 640 1.239 162 445 274
2023/20245.797 261 645 1.048 344 391 783 239 945 112 415 359 255
2024/20252.178 1.395 783 0 0 0 0 0 0 0 0 0 0
Totale 57.201